Your browser doesn't support javascript.
loading
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Maggino, Laura; Malleo, Giuseppe; Crippa, Stefano; Belfiori, Giulio; Nobile, Sara; Gasparini, Giulia; Lionetto, Gabriella; Luchini, Claudio; Mattiolo, Paola; Schiavo-Lena, Marco; Doglioni, Claudio; Scarpa, Aldo; Bassi, Claudio; Falconi, Massimo; Salvia, Roberto.
Affiliation
  • Maggino L; Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, Verona, Italy.
  • Malleo G; Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, Verona, Italy.
  • Crippa S; Unit of Pancreatic Surgery, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
  • Belfiori G; Unit of Pancreatic Surgery, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
  • Nobile S; Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, Verona, Italy.
  • Gasparini G; Unit of Pancreatic Surgery, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
  • Lionetto G; Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, Verona, Italy.
  • Luchini C; Department of Diagnostics and Public Health, Section␣of Pathology, University of Verona Hospital Trust, Verona, Italy.
  • Mattiolo P; Department of Diagnostics and Public Health, Section␣of Pathology, University of Verona Hospital Trust, Verona, Italy.
  • Schiavo-Lena M; Division of Pathology, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
  • Doglioni C; Division of Pathology, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
  • Scarpa A; Department of Diagnostics and Public Health, Section␣of Pathology, University of Verona Hospital Trust, Verona, Italy.
  • Bassi C; Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, Verona, Italy.
  • Falconi M; Unit of Pancreatic Surgery, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Vita-Salute University, Milan, Italy.
  • Salvia R; Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, Verona, Italy. roberto.salvia@univr.it.
Ann Surg Oncol ; 30(1): 222-223, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36333571
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Italy Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Ann Surg Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Italy Country of publication: United States